Silver Grove Financial Group »

Zenas Biopharma shares owned by Silver Grove Financial Group

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Silver Grove Financial Group from 13F filings

Historical chart of Silver Grove Financial Group investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Silver Grove Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Silver Grove Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $14k 538 25.38

More positions owned by Silver Grove Financial Group

Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Advisors Inner Circle Fd Ii 3edge Fixed Etf (EDGF)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Ishares Tr National Mun Etf (MUB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Silver Grove Financial Group

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma